NT
Neurotech International Limited
NTI.AX · ASX
$0.01 -3.70% (-$0.00)
1M -15.63%
Market Cap $13.6M
P/E Ratio -
Div. Yield -
ROE 172.29%
Bulios Fair Price
$0.01
23.1% downside
Trenutna cena
$0.013
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica NTI.AX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 22.32x
EV/FFO N/A
P/E N/A
Growth
0 /100
Declining Book val. growth 46.37%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 237.99%
ROIC 1,075.52%
Asset turnover 0.00x
Debt
86 /100
Low Current ratio 1.29x
Debt/Equity 0.00x
Debt/Assets N/A
Stability
3 /100
Unstable EPS volatility 73.12%
Beta 0.02x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NTI.AX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Anthony Filippis
Employees
18
Headquarters
Melbourne
Prihajajoči dogodki
02 MAR.
Earnings
Upcoming earnings report